Cann Group Ltd. · ASX:CAN

Cann — Corporate Update (October 2018)

9 slides from Cann's corporate update, Oct 30, 2018

  1. Slide 1: Market update

    GROUP LIMITED Market update October 2018 1 Shining light on medicinal cannabis

  2. Slide 2: Mission

    Mission Supply high-quality, trusted & innovative medicinal cannabis products & delivery platforms to enhance the wellbeing of patients in Australia & globally. 2 Shining light on medicinal cannabis

  3. Slide 3: Cann Group is building a sustainable growth platform

    Cann Group is building a sustainable growth platform Our objective is to be the Australian industry leader & to quickly build sufficient capacity/capability to service expanding export markets 3 Shining light on medicinal cannabis

  4. Slide 4: 24 harvests successfully completed

    24 harvests successfully completed • Cann has successfully completed 24 harvests • New capacity added at Southern facility • First full medicinal crop now underway at Northern facility • New supply agreement executed with Victorian Government • Imported genetics recently cleared by Australian quaran

  5. Slide 5: Major expansion plans progressing: Project Tullamarine

    Major expansion plans progressing: Project Tullamarine • World scale greenhouse, associated support areas & GMP standard production rooms for final form medicinal cannabis product • Heads of agreement signed with Australia Pacific Airports (Melbourne) Pty Ltd (APAM) to secure site • Aurora Larssen P

  6. Slide 6: Project Tullamarine provides a clear pathway to sustained profitability

    Project Tullamarine provides a clear pathway to sustained profitability • First design phase completed • Vendor bid specifications for greenhouse, warehouse, support building and utilities released this week • Workforce planning underway: Recruitment to start Q2 2019 Construction to Stage 1 commissi

  7. Slide 7: Strengthening our capabilities via key partnerships

    Strengthening our capabilities via key partnerships • New research collaboration agreement signed with CSIRO • Research MOU executed with Agriculture Victoria • Extension of agreement with La Trobe University: Focus on genetics; breeding & cultivation • Manufacturing agreement with IDT Australia Ltd

  8. Slide 8: Large & growing global market opportunity

    Large & growing global market opportunity The global medicinal cannabis market is estimated to reach US$100 billion by 2025, with an estimated growth rate of over 30% CAGR1. Global Market growth Year USD Mn 2015 5,610 The key driver for global growth is increasing 2016 7,644 legalisation. Medicinal

  9. Slide 9: Contacts

    GROUP LIMITED CONTACTS: Peter Crock CEO Cann Group Limited +61 (0)3 9095 7088 contact@canngrouplimited.com INVESTOR / MEDIA RELATIONS Matthew Wright NWR Communications +61 (0)451 896 420 matt@nwrcommunications.com.au 9 Shining light on medicinal cannabis

Cann Group — Corporate Update (October 2018) on 6ix